Geode Capital Management, LLC Wave Life Sciences Ltd. Transaction History

Geode Capital Management, LLC

  • $1.07 Trillion
  • Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,912,742 shares of WVE stock, worth $12.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,912,742
Previous 1,459,764 31.03%
Holding current value
$12.5 Million
Previous $7.37 Million 60.1%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$3.54 - $6.84 $1.6 Million - $3.1 Million
452,978 Added 31.03%
1,912,742 $11.8 Million
Q4 2023

Feb 13, 2024
BUY
$4.16 - $6.87 $268,848 - $443,987
64,627 Added 4.63%
1,459,764 $7.37 Million
Q3 2023

Nov 13, 2023
BUY
$3.56 - $5.75 $233,044 - $376,406
65,462 Added 4.92%
1,395,137 $8.02 Million
Q2 2023

Aug 11, 2023
BUY
$3.51 - $4.69 $2.24 Million - $2.99 Million
636,873 Added 91.93%
1,329,675 $4.84 Million
Q1 2023

May 15, 2023
BUY
$3.58 - $6.3 $98,228 - $172,859
27,438 Added 4.12%
692,802 $3 Million
Q4 2022

Feb 13, 2023
BUY
$3.18 - $7.0 $255,767 - $563,010
80,430 Added 13.75%
665,364 $4.66 Million
Q3 2022

Nov 14, 2022
BUY
$2.37 - $4.28 $327,401 - $591,256
138,144 Added 30.92%
584,934 $2.11 Million
Q2 2022

Aug 12, 2022
SELL
$1.23 - $3.25 $380,916 - $1.01 Million
-309,688 Reduced 40.94%
446,790 $1.45 Million
Q1 2022

May 13, 2022
SELL
$2.0 - $3.28 $40,970 - $67,190
-20,485 Reduced 2.64%
756,478 $1.51 Million
Q4 2021

Feb 11, 2022
BUY
$3.14 - $5.15 $463,027 - $759,424
147,461 Added 23.43%
776,963 $2.44 Million
Q3 2021

Nov 12, 2021
SELL
$4.89 - $7.12 $260,490 - $379,282
-53,270 Reduced 7.8%
629,502 $3.08 Million
Q2 2021

Aug 13, 2021
BUY
$5.65 - $7.47 $187,817 - $248,317
33,242 Added 5.12%
682,772 $4.55 Million
Q1 2021

May 12, 2021
BUY
$5.61 - $12.01 $114,853 - $245,880
20,473 Added 3.25%
649,530 $3.64 Million
Q4 2020

Feb 12, 2021
BUY
$6.99 - $9.26 $2.17 Million - $2.88 Million
310,515 Added 97.48%
629,057 $4.95 Million
Q3 2020

Nov 13, 2020
BUY
$8.49 - $19.54 $159,764 - $367,703
18,818 Added 6.28%
318,542 $2.7 Million
Q2 2020

Aug 13, 2020
BUY
$7.44 - $11.29 $42,341 - $64,251
5,691 Added 1.94%
299,724 $3.12 Million
Q1 2020

May 14, 2020
BUY
$6.94 - $14.22 $97,777 - $200,345
14,089 Added 5.03%
294,033 $2.76 Million
Q4 2019

Feb 13, 2020
SELL
$7.99 - $37.6 $7,015 - $33,012
-878 Reduced 0.31%
279,944 $2.24 Million
Q3 2019

Nov 12, 2019
BUY
$19.17 - $27.4 $237,957 - $340,116
12,413 Added 4.62%
280,822 $5.77 Million
Q2 2019

Aug 14, 2019
BUY
$22.93 - $42.84 $650,065 - $1.21 Million
28,350 Added 11.81%
268,409 $7 Million
Q1 2019

May 14, 2019
BUY
$32.69 - $47.91 $1.52 Million - $2.23 Million
46,464 Added 24.0%
240,059 $9.33 Million
Q4 2018

Feb 13, 2019
BUY
$37.1 - $50.11 $581,134 - $784,923
15,664 Added 8.8%
193,595 $8.14 Million
Q3 2018

Nov 13, 2018
BUY
$36.35 - $55.2 $323,805 - $491,721
8,908 Added 5.27%
177,931 $8.9 Million
Q2 2018

Aug 14, 2018
BUY
$33.85 - $50.65 $973,796 - $1.46 Million
28,768 Added 20.51%
169,023 $6.47 Million
Q1 2018

May 15, 2018
BUY
$32.45 - $54.7 $222,509 - $375,077
6,857 Added 5.14%
140,255 $5.62 Million
Q4 2017

Feb 13, 2018
SELL
$21.8 - $39.35 $8,131 - $14,677
-373 Reduced 0.28%
133,398 $4.68 Million
Q3 2017

Nov 14, 2017
BUY
$16.4 - $25.05 $12,906 - $19,714
787 Added 0.59%
133,771 $2.91 Million
Q2 2017

Aug 14, 2017
BUY
N/A
132,984
132,984 $2.47 Million

Others Institutions Holding WVE

# of Institutions
138
Shares Held
72.2M
Call Options Held
86.1K
Put Options Held
20.1K
View Full List

About Wave Life Sciences Ltd.

WVE Quotes by TradingView
  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $567M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email